Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making significant ...

Deutsche Bank has recently raised Boston Scientific Corp (BSX) stock to Buy rating, as announced on January 10, 2025, according to Finviz. Earlier, on October 18, 2024, Needham had reduced the stock ...

Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $98.17 which represents a slight increase of $1.28 or 1.32% from the prior close of $96.89. The stock opened at $97.03 and ...

The company’s third-quarter earnings report for fiscal 2024 showed strong sales growth and adjusted per-share earnings of ...

We recently compiled a list of the Billionaire Israel Englander’s Top 10 Stock Picks Heading Into 2025. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) ...

On the financial side, the company reported strong third-quarter 2024 results, with net sales of $4.209 billion — a 19.4% increase year-over-year on a reported basis — driven by sales growth in both ...

For 10 consecutive years, sales showed an increase, except for the pandemic year. If the growth of the Company satisfies me, the way it generates profits truly impresses me. Boston Scientific has ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

At the J.P. Morgan Healthcare Conference, Boston Scientific forecast that pulsed field ablation will be used in more than 60% of atrial fibrillation procedures globally by 2026.